Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 4834201, 8 pages
https://doi.org/10.1155/2017/4834201
Research Article

Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema

1Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan
2Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan

Correspondence should be addressed to Meng-Ju Tsai; moc.liamtoh@9290regor

Received 21 April 2017; Revised 9 June 2017; Accepted 9 July 2017; Published 27 July 2017

Academic Editor: Enrico Peiretti

Copyright © 2017 Meng-Ju Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Lee, T. Y. Wong, and C. Sabanayagam, “Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss,” Eye and Vision, vol. 2, p. 17, 2015. View at Publisher · View at Google Scholar
  2. M. Capitao and R. Soares, “Angiogenesis and inflammation crosstalk in diabetic retinopathy,” Journal of Cellular Biochemistry, vol. 117, no. 11, pp. 2443–2453, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Yamagishi, S. Ueda, T. Matsui, K. Nakamura, and S. Okuda, “Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy,” Current Pharmaceutical Design, vol. 14, no. 10, pp. 962–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Wells, A. R. Glassman, A. R. Ayala et al., “Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial,” Ophthalmology, vol. 123, no. 6, pp. 1351–1359, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Brown, Q. D. Nguyen, D. M. Marcus et al., “Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE,” Ophthalmology, vol. 120, no. 10, pp. 2013–2022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Sophie, N. Lu, and P. A. Campochiaro, “Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab,” Ophthalmology, vol. 122, no. 7, pp. 1395–1401, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. G. G. Deak, M. Bolz, M. Ritter et al., “A systematic correlation between morphology and functional alterations in diabetic macular edema,” Investigative Ophthalmology & Visual Science, vol. 51, no. 12, pp. 6710–6714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Murakami and N. Yoshimura, “Structural changes in individual retinal layers in diabetic macular edema,” Journal of Diabetes Research, vol. 2013, Article ID 920713, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Marmor, “Control of subretinal fluid: experimental and clinical studies,” Eye (London, England), vol. 4, Part 2, pp. 340–344, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ota, K. Nishijima, A. Sakamoto et al., “Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment,” Ophthalmology, vol. 117, no. 10, pp. 1996–2002, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Gupta, R. Raman, K. Mohana, V. Kulothungan, and T. Sharma, “Communications between intraretinal and subretinal space on optical coherence tomography of neurosensory retinal detachment in diabetic macular edema,” Oman Journal of Ophthalmology, vol. 6, no. 3, pp. 183–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sonoda, T. Sakamoto, M. Shirasawa, T. Yamashita, H. Otsuka, and H. Terasaki, “Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema,” Investigative Ophthalmology & Visual Science, vol. 54, no. 8, pp. 5367–5374, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. H. Wong, G. C. Cheung, S. P. Chee, and R. Mathur, “Exudative detachment as a masquerader in hypoalbuminaemic patients,” Clinical Kidney Journal, vol. 7, no. 4, pp. 406–410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. N. K. Koo and Y. C. Kim, “Resolution of macular edema after systemic treatment with furosemide,” Korean Journal of Ophthalmology, vol. 26, no. 4, pp. 312–315, 2012. View at Publisher · View at Google Scholar
  15. R. E. Man, M. B. Sasongko, J. J. Wang et al., “The association of estimated glomerular filtration rate with diabetic retinopathy and macular edema,” Investigative Ophthalmology & Visual Science, vol. 56, no. 8, pp. 4810–4816, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Patel, A. C. Browning, F. K. Chen, L. Cruz, and A. Tufail, “Interobserver agreement for the detection of optical coherence tomography features of neovascular age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 50, no. 11, pp. 5405–5410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Turgut, F. C. Gul, N. Ilhan, T. Demir, and U. Celiker, “Comparison of serum glycosylated hemoglobin levels in patients with diabetic cystoid macular edema with and without serous macular detachment,” Indian Journal of Ophthalmology, vol. 58, no. 5, pp. 381–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gupta, R. Raman, V. Kulothungan, and T. Sharma, “Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case-control study,” BMC Ophthalmology, vol. 14, p. 47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Young, H. Wang, S. Munk et al., “Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent,” Experimental Eye Research, vol. 80, no. 5, pp. 651–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. B. Caldwell, M. Bartoli, M. A. Behzadian et al., “Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress,” Current Drug Targets, vol. 6, no. 4, pp. 511–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Jain, S. Saxena, V. K. Khanna, R. K. Shukla, and C. H. Meyer, “Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus,” Molecular Vision, vol. 19, pp. 1760–1768, 2013. View at Google Scholar
  22. D. R. Cha, N. H. Kim, J. W. Yoon et al., “Role of vascular endothelial growth factor in diabetic nephropathy,” Kidney International. Supplement, vol. 77, pp. S104–S112, 2000. View at Google Scholar
  23. X. Li, T. T. Wu, J. Chen, and W. Qiu, “Elevated expression levels of serum insulin-like growth factor-1, tumor necrosis factor-alpha and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy,” Journal of Diabetes Investigation, vol. 8, no. 1, pp. 108–114, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. D. R. Cha, Y. S. Kang, S. Y. Han et al., “Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats,” The Journal of Endocrinology, vol. 183, no. 1, pp. 183–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Kanesaki, D. Suzuki, G. Uehara et al., “Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy,” American Journal of Kidney Diseases, vol. 45, no. 2, pp. 288–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. The Diabetes Control and Complications Trial Research Group, “Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial,” Archives Ophthalmology, vol. 116, no. 7, pp. 874–886, 1998. View at Publisher · View at Google Scholar
  27. K. Dahl-Jorgensen, O. Brinchmann-Hansen, K. F. Hanssen, L. Sandvik, and O. Aagenaes, “Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo Study,” British Medical Journal (Clinical Research Ed.), vol. 290, no. 6471, pp. 811–815, 1985. View at Google Scholar
  28. A. S. Bansal, R. N. Khurana, M. R. Wieland, P. W. Wang, S. A. Everen, and L. Tuomi, “Influence of glycosylated hemoglobin on the efficacy of ranibizumab for diabetic macular edema: a post hoc analysis of the RIDE/RISE trials,” Ophthalmology, vol. 122, no. 8, pp. 1573–1579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Klaassen, C. J. V. Noorden, and R. O. Schlingemann, “Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions,” Progress in Retinal and Eye Research, vol. 34, pp. 19–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Negi and M. F. Marmor, “Effects of subretinal and systemic osmolality on the rate of subretinal fluid resorption,” Investigative Ophthalmology & Visual Science, vol. 25, no. 5, pp. 616–620, 1984. View at Google Scholar
  31. D. Zhu, H. Zhu, C. Wang, and D. Yang, “Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema,” Indian Journal of Ophthalmology, vol. 62, no. 3, pp. 295–298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. K. G. Falavarjani, J. Khadamy, F. Amirkourjani, H. Safi, and M. Modarres, “Macular thickness measurement in clinically significant macular edema before and after meal,” Journal of Current Ophthalmology, vol. 27, no. 3-4, pp. 125–128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. D. N. Thornit, C. M. Vinten, B. Sander, H. Lund-Andersen, and M. Cour, “Blood-retinal barrier glycerol permeability in diabetic macular edema and healthy eyes: estimations from macular volume changes after peroral glycerol,” Investigative Ophthalmology & Visual Science, vol. 51, no. 6, pp. 2827–2834, 2010. View at Publisher · View at Google Scholar · View at Scopus